U.S. Professional Services Stock News

NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks

Aurinia Pharmaceuticals, ticker NasdaqGM:AUPH, has agreed to acquire Kezar Life Sciences to expand its autoimmune disease portfolio. The deal includes Kezar’s clinical candidate zetomipzomib and has received approval from Kezar’s board. The transaction is expected to close soon, pending remaining customary conditions. Aurinia Pharmaceuticals enters this deal with its shares at $15.79 and a 1 year return of 119.3%. Over shorter periods, the stock has seen returns of 6.5% over the past week...
NYSE:ASB
NYSE:ASBBanks

Associated Banc-Corp Merger And New Director Shape Midwest Growth Story

Associated Banc-Corp (NYSE:ASB) has completed its merger with American National Corporation, expanding its market reach. The transaction adds to ASB's total assets and presence in key banking markets. Following the merger, former American National Bank executive Wende Kotouc has been appointed to ASB's Board of Directors. Associated Banc-Corp operates as a regional banking group, offering services such as lending, deposits, and treasury management to retail and commercial clients. With this...
NasdaqGS:ADV
NasdaqGS:ADVMedia

Top Undervalued Small Caps With Insider Buying In April 2026

The United States market has shown a positive trend, increasing by 1.2% over the last week and climbing 33% in the past year, with earnings projected to grow by 16% annually in the coming years. In this environment, identifying stocks that are potentially undervalued while also exhibiting insider buying can be an effective strategy for investors seeking opportunities within small-cap companies.
NYSE:YOU
NYSE:YOUSoftware

3 Stocks Estimated To Be Undervalued In April 2026

The United States market has shown robust performance, climbing 1.2% in the last 7 days and up 33% over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying stocks that are potentially undervalued can offer opportunities for investors seeking to capitalize on growth prospects while maintaining a focus on value.
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Top Growth Companies With High Insider Ownership In April 2026

The United States market has shown robust performance, climbing 1.2% in the last week and an impressive 33% over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership are particularly noteworthy as they often indicate strong alignment between management and shareholder interests, potentially enhancing investor confidence.
NasdaqGM:ACIU
NasdaqGM:ACIUBiotechs

April 2026's Most Promising Penny Stocks

The U.S. market has experienced a notable climb, rising 1.2% in the last week and 33% over the past year, with earnings projected to grow significantly in the coming years. In such a robust market climate, identifying stocks with strong financial foundations is crucial for investors seeking value beyond established names. Penny stocks, often representing smaller or newer companies, remain an intriguing investment area despite their somewhat outdated label; they can offer surprising...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

BWX Technologies’ New Enrichment Move And What It Means For Valuation

BWX Technologies (NYSE:BWXT) has begun the regulatory process to license a new uranium enrichment facility in Erwin, Tennessee. The facility is intended to support a major U.S. defense nuclear fuels contract and use advanced centrifuge technology developed with the Department of Energy. The project is tied to a previously announced $1.5b contract with the National Nuclear Security Administration for naval and defense fuel supply. For investors watching defense and nuclear infrastructure,...
NYSE:UNH
NYSE:UNHHealthcare

US Stock Market Today S&P 500 Futures Rally On Ceasefire Hopes And CPI Watch

The Morning Bull - US Market Morning Update Wednesday, Apr, 8 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 2.6% and Nasdaq-100 futures roughly 3.4% firmer, as a ceasefire push in the Middle East pulls the VIX volatility gauge down around 12%. Government bond yields are reacting too, with the US 10 year near 4.25% while markets wait for Friday’s CPI, a key scorecard for the pace of price increases. Lower volatility and easier bond markets tend...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Axon Deepens AI And Cloud Role Across Public Safety Workflows

Axon Enterprise (NasdaqGS:AXON) has launched Axon Vision for AI-powered real-time event detection across live video feeds. The company has expanded Axon Assistant with additional secure AI features to support day to day policing and administrative tasks. Axon introduced Axon 911, a cloud based platform designed to reshape emergency response workflows for public safety agencies. Axon Enterprise focuses on public safety technology, connecting hardware, software, and digital services for law...
NYSE:WS
NYSE:WSMetals and Mining

How Investors May Respond To Worthington Steel (WS) Mixed Q3 Earnings And Steady Dividend Declaration

Worthington Steel, Inc. has reported its third-quarter and nine-month results to February 28, 2026, with sales rising to US$769.8 million and US$2.51 billion respectively, while quarterly net income and earnings per share eased compared with the prior year, and the board declared a US$0.16 quarterly dividend payable June 26, 2026. An interesting contrast emerges as nine-month net income increased to US$66.0 million year on year even though third-quarter earnings and per-share results...
NYSE:UTI
NYSE:UTIConsumer Services

Is It Too Late To Consider Universal Technical Institute (UTI) After Its Strong Year To Date Run?

If you are wondering whether Universal Technical Institute at around US$36.29 is priced for opportunity or already reflects the story you are buying into, this article walks through what the current valuation is actually indicating. The stock has returned 0.5% over the last 7 days, 3.7% over the last 30 days and 46.1% year to date, with a 39.1% return over the last year and a very large gain over 5 years. Recent coverage around Universal Technical Institute has focused on its role in the...
NYSE:UHAL
NYSE:UHALTransportation

Is It Time To Reconsider U-Haul Holding (UHAL) After Prolonged Share Price Weakness?

Wondering whether U-Haul Holding is a bargain or a value trap at around US$48.76? This breakdown will help you size up the stock with a clear valuation lens. The share price has moved 2.1% over the last 7 days, while returns sit at a 2.2% decline over 30 days and a 3.5% decline year to date, with a 16.9% decline over the past year and 19.9% and 20.4% declines across the 3 and 5 year periods respectively. Recent coverage has focused on U-Haul Holding as a long established name in do it...
NasdaqGS:ITRN
NasdaqGS:ITRNCommunications

Is It Too Late To Consider Ituran Location And Control (ITRN) After Its Strong Share Price Run

Investors may be wondering whether Ituran Location and Control is still priced attractively after a strong run, or if most of the easy gains are already on the table. The stock last closed at US$51.48, with returns of 5.0% over 7 days, 3.9% over 30 days, 21.1% year to date, 74.1% over 1 year, 179.8% over 3 years and 192.4% over 5 years. This performance may have changed how investors are thinking about risk and reward. Recent company news has kept Ituran Location and Control in focus for...
NasdaqGS:DORM
NasdaqGS:DORMAuto Components

Dorman Products Unites CEO And Chairman Roles Under Kevin Olsen

Dorman Products (NasdaqGS:DORM) has appointed President and CEO Kevin Olsen as Chairman of the Board. Former Chairman Steven Berman will remain on the board following this leadership change. The move combines the CEO and Chairman roles, signaling a new governance structure for the company. Dorman Products, which focuses on replacement parts for the automotive aftermarket, now has Kevin Olsen serving as President, CEO and Chairman. For investors, this kind of leadership consolidation can...
NasdaqGS:MLYS
NasdaqGS:MLYSBiotechs

A Look At Mineralys Therapeutics (MLYS) Valuation After FDA Accepts Lorundrostat NDA For Hypertension

Regulatory milestone for lorundrostat Mineralys Therapeutics (MLYS) recently reported that the FDA accepted its New Drug Application for lorundrostat in hypertension, while also updating investors on the Explore OSA trial in obstructive sleep apnea. See our latest analysis for Mineralys Therapeutics. Mineralys Therapeutics’ share price has pulled back over the past quarter, with a 90 day share price return of 19.92% decline and year to date return of 20.72% decline. However, the 1 year total...